Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Anesth ; 35(4): 495-504, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-34008073

RESUMO

BACKGROUND: This study aimed to evaluate the influence of anesthetic management with propofol or sevoflurane on the prognosis of patients undergoing gynecologic cancer surgery. METHODS: This retrospective cohort study included patients who underwent gynecologic cancer (cervical, endometrial, and ovarian cancer) surgery between 2006 and 2018 at the National Hospital Organization Osaka National Hospital. Patients were grouped according to anesthesia type for maintenance of anesthesia: propofol or sevoflurane. After propensity score matching, Kaplan-Meier survival curves were constructed for overall survival, cancer-specific survival, and recurrence-free survival. Univariate and multivariate cox regression models were used to compare hazard ratios for recurrence-free survival. RESULTS: A total of 193 patients with propofol and 94 with sevoflurane anesthesia were eligible for analysis. After propensity score matching, 94 patients remained in each group. The sevoflurane group showed significantly lower survival rates than the propofol group with respect to 10-year overall survival (89.3% vs. 71.6%; p = 0.007), 10-year cancer-specific survival (91.0% vs 80.2%; p = 0.039), and 10-year recurrence-free survival (85.6% vs. 67.7%; p = 0.008). Sevoflurane anesthesia was identified as an independent risk factor for recurrence-free survival. Furthermore, distant recurrence was significantly more frequent in the sevoflurane group than in the propofol group (p < 0.001). CONCLUSION: In patients undergoing gynecologic cancer surgery, sevoflurane anesthesia was associated with worse overall, cancer-specific, and recurrence-free survival than propofol anesthesia.


Assuntos
Anestésicos Inalatórios , Éteres Metílicos , Neoplasias , Propofol , Anestesia Geral/efeitos adversos , Anestésicos Intravenosos , Feminino , Humanos , Estudos Retrospectivos , Sevoflurano
2.
J Nippon Med Sch ; 87(2): 80-86, 2020 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-31902853

RESUMO

Pseudo-Meigs syndrome is defined as secondary accumulation of ascites and hydrothorax associated with a pelvic tumor other than benign ovarian tumors such as fibroma, which usually resolve after surgical removal of the tumor. Here we report a case of pseudo-Meigs syndrome caused by a giant uterine leiomyoma, which was initially suspected to be ovarian cancer. A 37-year-old nulliparous woman presented with a 5-month history of abdominal distension and anorexia. Abdominal ultrasonography revealed a giant cystic lesion and solid mass in the peritoneal cavity, along with plentiful ascites. Chest X-ray images showed a small pleural effusion on the right side. The patient was referred to our hospital for treatment of suspected ovarian cancer and peritonitis carcinomatosis. Although serum CA125 level was elevated (up to 331.8 U/mL), magnetic resonance imaging showed a giant sub-serosal uterine leiomyoma with cystic degeneration (27 × 15 × 13 cm). A small dermoid cyst was also detected in the right ovary. Ascites was drained and the patient underwent myomectomy and ovarian cystectomy. The patient had a degenerated leiomyoma with no pathological evidence of malignancy. Because symptoms disappeared postoperatively and serum CA125 returned to normal, without recurrence of ascites, pseudo-Meigs syndrome was diagnosed.


Assuntos
Cistos/complicações , Leiomioma/complicações , Síndrome de Meigs/etiologia , Doenças Ovarianas/complicações , Neoplasias Uterinas/complicações , Adulto , Biomarcadores Tumorais/sangue , Antígeno Ca-125/sangue , Cistos/diagnóstico , Cistos/patologia , Feminino , Humanos , Leiomioma/diagnóstico , Leiomioma/patologia , Síndrome de Meigs/diagnóstico , Síndrome de Meigs/patologia , Doenças Ovarianas/diagnóstico , Doenças Ovarianas/patologia , Neoplasias Uterinas/diagnóstico , Neoplasias Uterinas/patologia
3.
Mol Cell Endocrinol ; 490: 57-67, 2019 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-30981734

RESUMO

In the human placenta, extravillous trophoblasts (EVTs) invade maternal decidual tissues (interstitial trophoblasts) and maternal spiral arteries (endovascular trophoblasts). Although endovascular trophoblasts are directly exposed to maternal blood containing complement components, they are not eliminated by complement-dependent cytotoxicity (CDC). In this study, we investigated the expression and possible function of CD59, one of the membrane-bound complement regulators, in EVTs. Immunohistochemistry of early embryo implantation sites revealed that CD59 was hardly expressed on interstitial trophoblasts, whereas it was intensely expressed on endovascular trophoblasts. Using the human EVT-like cell line Swan71, we established CD59-silencing Swan71 cells (Sw_CD59sh) and non-silencing control Swan71 cells (Sw_CTRsh). In vitro cell apoptosis assay showed that Sw_CD59sh cells were significantly more susceptible to CDC as compared to Sw_CTRsh. Our results suggest that CD59 confers some protection against maternal complement attack to the endovascular trophoblasts.


Assuntos
Antígenos CD59/metabolismo , Proteínas do Sistema Complemento/metabolismo , Citotoxicidade Imunológica , Trofoblastos/metabolismo , Hipóxia Celular , Linhagem Celular , Complexo de Ataque à Membrana do Sistema Complemento/metabolismo , Decídua/metabolismo , Implantação do Embrião/genética , Feminino , Regulação da Expressão Gênica , Humanos , Gravidez
4.
Curr Pharm Biotechnol ; 19(10): 764-770, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30378495

RESUMO

The invasion of an extravillous trophoblast (EVT) into maternal decidual tissues, especially towards maternal spiral arteries, is an essential process in the human placental formation and subsequent normal fetal development. However, the precise regulatory mechanisms to induce EVT invasion towards arteries and/or to protect EVT from further invasion are not well understood. We found that a chemokine receptor, CCR1, was specifically expressed on EVT migrating towards maternal arteries. Using EVT isolated from a primary villous explant culture, RANTES, which is one of the ligands for CCR1, was shown to enhance EVT invasion. Furthermore, we observed that the platelets were deposited among intravascular EVT and platelet-derived soluble factors, which contained RANTES, enhanced EVT invasion. On the one hand, dipeptidyl peptidase IV (DPPIV), which can metabolize RANTES on the cell surface, was expressed on non-invading EVT and was demonstrated to suppress EVT invasion. In contrast, laeverin/aminopeptidase Q, which is specifically expressed on EVT, was shown to induce EVT invasion. Also, CD9 which is a cell surface marker of platelets and a regulator of integrin function was expressed on EVT and gene knockdown of the CD9 molecule enhanced EVT invasion. These findings suggest that the chemokine-chemokine receptor, chemokine-peptidase, and CD9-integrin systems play important roles in the regulation of EVT invasion during early human placental formation.


Assuntos
Quimiocinas/metabolismo , Dipeptidil Peptidase 4/metabolismo , Placenta/metabolismo , Tetraspanina 29/metabolismo , Trofoblastos/metabolismo , Plaquetas/metabolismo , Movimento Celular/fisiologia , Quimiocina CCL5/metabolismo , Feminino , Humanos , Integrinas/metabolismo , Placentação/fisiologia , Gravidez
5.
Am J Reprod Immunol ; 77(4)2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28168784

RESUMO

PROBLEM: We previously proposed that platelets promote re-epithelialization during menstruation. As cell movement is one of the important cell behaviors in the process of tissue remodeling, we examined the effects of platelets on endometrial epithelial cell invasion. METHOD OF STUDY: The platelets were isolated from healthy women. Using a human endometrial epithelial cell-derived immortalized cell line, EM-E6/E7/hTERT cells, we examined the effects of platelets and platelet-derived condition media with or without microparticles on the morphological and invasive properties of EM-E6/E7/hTERT cells. RESULTS: Platelets and microparticle-containing conditioned media inhibited Matrigel invasion by EM-E6/E7/hTERT cells along with an increase in cortical ring formation, whereas microparticle-depleted conditioned media promoted their invasion without any significant changes of cortical ring formation. CONCLUSION: These results support our previous proposal and newly suggest the dual roles of platelets: platelet-derived soluble factors that promote cell movement in the distant area, and microparticles that induce re-epithelialization by endometrial epithelial cells in the proximal area.


Assuntos
Plaquetas/metabolismo , Movimento Celular/fisiologia , Micropartículas Derivadas de Células/metabolismo , Endométrio/citologia , Células Epiteliais/citologia , Células Cultivadas , Feminino , Citometria de Fluxo , Humanos
6.
Am J Reprod Immunol ; 77(1)2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27868276

RESUMO

PROBLEM: The human endometrium periodically breaks down and regenerates. As platelets have been reported to contribute to the tissue remodeling process, we examined the possible involvement of platelets in endometrial regeneration. METHOD OF STUDY: The distribution of extravasating platelets throughout the menstrual cycle was immunohistochemically examined using human endometrial tissues. EM-E6/E7/hTERT cells, a human endometrial epithelial cell-derived immortalized cell line, were co-cultured with platelets, and the effects of platelets on the epithelialization response of EM-E6/E7/hTERT cells were investigated by attachment and permeability assays, immunohistochemical staining, and Western blot analysis. RESULTS: Immunohistochemical study showed numerous extravasated platelets in the subluminar stroma during the menstrual phase. The platelets promoted the cell-to-matrigel attachment of EM-E6/E7/hTERT cells concomitantly with the phosphorylation of focal adhesion kinase. They also promoted cell-to-cell contact among EM-E6/E7/hTERT cells in parallel with E-cadherin expression. CONCLUSION: These results indicate the possible involvement of platelets in the endometrial epithelial re-epithelialization process.


Assuntos
Plaquetas/fisiologia , Endométrio/patologia , Células Epiteliais/imunologia , Menstruação/fisiologia , Reepitelização/fisiologia , Plaquetas/patologia , Caderinas/metabolismo , Adesão Celular , Linhagem Celular Transformada , Permeabilidade da Membrana Celular , Técnicas de Cocultura , Feminino , Proteína-Tirosina Quinases de Adesão Focal/metabolismo , Humanos , Fosforilação , Regeneração
7.
Placenta ; 47: 105-112, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27780531

RESUMO

During human placentation, the extravillous trophoblast (EVT) invades the maternal decidua and reconstructs maternal spiral arteries. However, the precise mechanisms that control EVT behavior have not yet been elucidated in detail. CD9 has been reported to be a cell-motility-related molecule. Since we previously observed that CD9 was expressed on human EVT, we examined the possible involvement of CD9 in the invasion process of EVT. Placental and umbilical samples were obtained from patients who underwent legal abortions, normal delivery, or hysterectomy. The expression of CD9 at the implantation site and on isolated EVT from a villous explant culture, an EVT-derived immortalized cell line, Swan71, and HUVEC was examined by immunocytochemical staining, flow cytometry, and RT-PCR. The effects of anti-CD9 functional antibody (ALB6) on EVT and Swan71 cell invasion were further examined by matrigel invasion assay along with shRNAmir gene knockdown treatment. CD9 was highly expressed on EVT at the boundary region of EVT invasion and intravascular EVT. EVT and Swan71 cell invasions were promoted by ALB6 or shRNAmir treatment. CD9 expression on Swan71 cells was reduced under hypo-oxygenic conditions, while its expression was increased by the co-culture with HUVEC. These findings suggest that CD9 could attenuate EVT invasion under the influence of an oxygen environment and maternal endothelial cells, proposing that CD9 is a potential regulator of human placental formation.


Assuntos
Movimento Celular/fisiologia , Placenta/metabolismo , Placentação/fisiologia , Tetraspanina 29/metabolismo , Trofoblastos/metabolismo , Cordão Umbilical/metabolismo , Vilosidades Coriônicas/metabolismo , Técnicas de Cocultura , Feminino , Técnicas de Silenciamento de Genes , Humanos , Placenta/citologia , Gravidez , RNA Interferente Pequeno , Tetraspanina 29/genética , Trofoblastos/citologia , Cordão Umbilical/citologia
8.
Int J Gynecol Cancer ; 23(3): 576-82, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23429488

RESUMO

OBJECTIVES: The Eph-ephrin system is a unique system that can induce multiple cellular responses such as cell migration, regulation of angiogenesis, and axonal guidance. Previously, the Eph-ephrin system was reported to regulate human extravillous trophoblast invasion. In this study, we examined the possible involvement of the Eph-ephrin system in the invasion of malignant gestational trophoblastic diseases using a human choriocarcinoma-derived cell line, JEG-3. METHODS: The mRNA expression of class A Ephs and ephrins on JEG-3 cells was examined by reverse transcription-polymerase chain reaction. The effects of recombinant human Eph A1 (r-Eph A1) and r-ephrin A4 on the proliferation and invasion of JEG-3 cells were investigated by cell proliferation and Matrigel invasion assays. The alterations of integrin expression on JEG-3 cells in the presence of r-Eph A1 and r-ephrin A4 were investigated by flow cytometry. The induction of phosphorylation of focal adhesion kinase in JEG-3 cells by r-ephrin A4 was examined by Western blot analysis. RESULTS: By reverse transcription-polymerase chain reaction, mRNAs of Eph A1, A2, and A4 and ephrin A1, A4, and A5 were detected on JEG-3 cells. In Matrigel invasion assay, both r-Eph A1 and r-ephrin A4 promoted the invasion of JEG-3 cells without affecting cell proliferation. During 24-hour culture with r-Eph A1 and r-ephrin A4, the increase in integrin α 5 expression on JEG-3 cells was observed by flow cytometry. Western blotting analysis showed that r-ephrin A4 induced dephosphorylation of focal adhesion kinase in JEG-3 cells. CONCLUSIONS: These findings suggest that Eph-ephrin interaction plays some role in the regulation of choriocarcinoma invasion in cooperation with integrins.


Assuntos
Movimento Celular , Coriocarcinoma/patologia , Efrinas/metabolismo , Integrinas/metabolismo , Receptores da Família Eph/metabolismo , Proteínas Recombinantes/metabolismo , Neoplasias Uterinas/patologia , Apoptose , Western Blotting , Adesão Celular , Proliferação de Células , Coriocarcinoma/genética , Coriocarcinoma/metabolismo , Colágeno/metabolismo , Combinação de Medicamentos , Efrinas/genética , Feminino , Citometria de Fluxo , Humanos , Integrinas/genética , Laminina/metabolismo , Gravidez , Proteoglicanas/metabolismo , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real , Receptores da Família Eph/genética , Proteínas Recombinantes/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células Tumorais Cultivadas , Neoplasias Uterinas/genética , Neoplasias Uterinas/metabolismo
9.
Hum Reprod ; 27(5): 1267-76, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22402206

RESUMO

BACKGROUND: In primate placenta, extravillous trophoblast (EVT) invades maternal tissue in temporally- and spatially-regulated fashions. We previously identified a novel placenta-specific cell-surface aminopeptidase, laeverin/aminopeptidase Q, which is expressed on EVT-lineage cells in the fetal membrane. Laeverin possesses a peptide-binding site that is evolutionally unique to primates, suggesting possible involvement of laeverin in a primate-specific phenomenon during placentation. Thus, this study was designed to elucidate the molecular characteristics and physiological roles of laeverin in human EVT. METHODS: Placental tissues of various developmental stages were subjected to immunostaining and western blotting. Effects of siRNA and a soluble form of recombinant laeverin on EVT cells isolated from primary villous explant cultures were examined using Matrigel invasion assays and cell proliferation assays. RESULTS: Laeverin was specifically immunolocalized to HLA-G-positive EVT in placentas from early and term pregnancy. In primary villous explant cultures, laeverin expression was induced on the cell surface of the outgrowing EVT. In western blotting, laeverin protein was detected as two distinct bands at 130 and 160 kDa along with a broad band ranging from 200 to 270 kDa. De-glycosylation treatment showed that these native laeverin isotypes are N-linked glycoproteins sharing a common 115-kDa core protein. In invasion assays, the reduction of laeverin expression by siRNA suppressed migration of the isolated EVT, while the soluble form of recombinant laeverin enhanced its migration. CONCLUSIONS: Laeverin is a specific cell-surface marker for human EVT and plays a regulatory role in EVT migration.


Assuntos
Proteínas de Membrana/fisiologia , Metaloproteases/fisiologia , Placentação/fisiologia , Trofoblastos/fisiologia , Biomarcadores , Diferenciação Celular , Movimento Celular , Proliferação de Células , Feminino , Antígenos HLA-G , Humanos , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Metaloproteases/genética , Metaloproteases/metabolismo , Placenta/metabolismo , Gravidez , Proteínas Recombinantes de Fusão/farmacologia , Proteínas Recombinantes de Fusão/fisiologia , Trofoblastos/metabolismo
10.
J Obstet Gynaecol Res ; 34(6): 1054-60, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19012708

RESUMO

Extrapulmonary small cell carcinomas are often associated with carcinomas of other cell types. Although a hypothesis that extrapulmonary small cell carcinomas arise from a multipotential stem cell could explain this mixed feature, recent molecular evidence supports another possibility that the small cell component may arise as a late-stage phenomenon in the progression of more organ-typical carcinomas. Here, we report a case of uterine cervical adenocarcinoma containing 30% of small cell carcinoma. Adenocarcinoma was located in the endometrial side of the tumor that was adjacent to the normal cervical region, while small cell carcinoma was located in the periphery of the tumor. The transition from adenocarcinoma to small cell carcinoma was observed in the boundary area. These findings suggest that cervical small cell carcinoma can be differentiated from pre-existing adenocarcinoma and offer further support to the hypothesis that the small cell component arises as a late-stage phenomenon in the progression of more organ-typical carcinomas.


Assuntos
Adenocarcinoma/patologia , Carcinoma de Células Pequenas/patologia , Neoplasias do Colo do Útero/patologia , Adenocarcinoma/cirurgia , Carcinoma de Células Pequenas/cirurgia , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias do Colo do Útero/cirurgia
11.
J Obstet Gynaecol Res ; 34(4 Pt 2): 605-8, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18840163

RESUMO

Budd-Chiari syndrome is a rather unusual clinical situation caused by occlusion of the hepatic vein of inferior vena cava, the classical triad of which are abdominal pain, ascites and hepatomegaly. A 29-year-old gravida 3 para 1 woman delivered an immature male baby weighing 2172 g with an Apgar score of 9 points at 35 weeks and 3 days of gestation. She was transferred to the National Hospital Organization Osaka National Hospital 112 days after delivery due to the sudden development of massive ascites. Magnetic resonance angiography and enhanced computed tomography detected the occlusion by thrombosis of both the middle and left hepatic veins, so she was diagnosed with Budd-Chiari syndrome. Her protein C antigen and activity were 37% and 50%, respectively, corresponding to type 1 protein C deficiency. Conservative treatment by continuous oral treatment of spironolactone (25 mg/day), furosemide (20 mg/day) and prophylactic warfarin (2 mg/day) much improved the ascites.


Assuntos
Ascite/diagnóstico , Síndrome de Budd-Chiari/diagnóstico , Transtornos Puerperais/diagnóstico , Adulto , Ascite/etiologia , Síndrome de Budd-Chiari/complicações , Feminino , Humanos , Recém-Nascido , Masculino , Gravidez , Nascimento Prematuro , Deficiência de Proteína C/complicações , Deficiência de Proteína C/diagnóstico , Transtornos Puerperais/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...